Fresenius Competitors

Pink Sheets . USA . 
Stock . Fresenius SE Co
FSNUF Stock  USD 32.16  0.00  0.00%   
Fresenius SE competes with IMAC Holdings, HCA Holdings, HUMANA, SCOR PK, and Barloworld; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Care Facilities industry. Analyzing Fresenius competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Fresenius to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Fresenius Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Fresenius competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fresenius' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
30.8532.1633.47
Details
Intrinsic
Valuation
LowRealHigh
28.9433.4934.81
Details

Fresenius Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Fresenius and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Fresenius and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Fresenius SE does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ID
+ 0.67
SCRYY
LBHIX
+ 0.67
MSTSX
444859BR2
+ 0.64
BACK
LBHIX
+ 0.53
ABHYX
ID
+ 0.51
LBHIX
444859BR2
+ 0.48
HCA
  
High negative correlations   
LBHIX
- 0.82
BACK
MSTSX
- 0.67
BACK
ID
- 0.66
444859BR2
ID
- 0.64
HCA
ID
- 0.6
BACK
LBHIX
- 0.58
444859BR2

Risk-Adjusted Indicators

There is a big difference between Fresenius Pink Sheet performing well and Fresenius Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fresenius' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BACK  3.56 (0.59) 0.00  3.22  0.00 
 0.00 
 7.32 
(7.91)
 23.76 
HCA  1.16 (0.27) 0.00 (2.43) 0.00 
 0.00 
 2.06 
(2.82)
 11.25 
444859BR2  1.31  0.03  0.00  0.07  0.00 
 0.00 
 5.93 
(4.56)
 16.62 
SCRYY  2.13  0.38  0.09 (0.82) 2.03 
(2.95)
 5.61 
(4.09)
 12.99 
AQUI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
BRRAY  1.27 (0.13) 0.00  0.01  0.00 
 0.00 
 0.00 
(2.98)
 34.02 
MSTSX  0.48 (0.05)(0.15) 0.04  0.53 
(0.58)
 1.03 
(1.02)
 2.80 
ABHYX  0.17  0.00 (0.25) 0.08  0.26 
(0.23)
 0.34 
(0.33)
 1.91 
LBHIX  0.11  0.01 (0.40) 0.46  0.00 
(0.29)
 0.24 
(0.24)
 0.96 
ID  3.65  0.47  0.08  0.69  4.00 
(4.87)
 7.32 
(6.67)
 20.54 
All Fundamental Data

Fresenius Competitive Analysis

The better you understand Fresenius competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Fresenius' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Fresenius' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
FSNUF BACK HCA 444859BR2 SCRYY AQUI BRRAY MSTSX ABHYX LBHIX
 0.00 
 32.16 
Fresenius
 2.80 
 1.04 
IMAC
 1.02 
 328.95 
HCA
 1.70 
 80.35 
HUMANA
 1.63 
 2.50 
SCOR
 0.00 
 0.01 
Aquagold
 0.00 
 4.23 
Barloworld
 1.28 
 11.88 
Morningstar
 0.33 
 8.96 
High-yield
 0.23 
 4.25 
Thrivent
Market Volatility
(90 Days Market Risk)
Very steady
Slightly risky
Very steady
Very steady
Risky
Very steady
Relatively risky
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
OK
Very Weak
Very Weak
Modest
Insignificant
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Very High
Low
Below Average
Below Average
Average
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Under Valued
Fairly Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Strong Buy
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Hold
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Hold
Strong Hold
Cautious Hold
Strong Sell
Current Ratio
1.32
1.18
1.38
N/A
9.99
N/A
1.49
N/A
N/A
N/A
Net Asset
71.96 B
1.14 M
56.21 B
N/A
51.52 B
3.19 K
54.41 B
116.1 M
672.37 M
674.44 M
EBITDA
4.16 B
(5.95 M)
12.72 B
N/A
1.23 B
(727.69 K)
2.77 B
N/A
N/A
N/A
Operating Margin
0.0881
N/A
0.14
N/A
-0.0092
N/A
0.1
N/A
N/A
N/A
Five Year Return
1.16
N/A
N/A
N/A
4.83
N/A
3.98
8.6
1.69
3.31
One Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
19.87
11.13
11.68
Beta
1.08
0.26
1.69
N/A
1.25
7.05
0.63
N/A
N/A
N/A
Number Of Employees
319.69 K
2
220 K
N/A
3.59 K
7
36
1
1
1
Three Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
7.0
-0.63
2.59
Cash Flow From Operations
5.08 B
(2.79 M)
9.43 B
N/A
2.41 B
(218.19 K)
1.89 B
N/A
N/A
N/A
Total Debt
27.16 B
1.9 M
41.86 B
N/A
3.05 B
N/A
8.64 B
N/A
N/A
N/A
Bond Positions Weight
N/A
N/A
N/A
N/A
N/A
N/A
N/A
22.72
2.0
92.23
Holdings Turnover
N/A
N/A
N/A
N/A
N/A
N/A
N/A
269.0
N/A
N/A
Return On Asset
0.0292
-0.38
0.12
N/A
-0.002
-5.5
0.047
N/A
N/A
N/A
Current Liabilities
8.45 B
N/A
5.52 B
N/A
N/A
794 K
13.9 B
N/A
N/A
N/A
Debt To Equity
0.89
0.35
N/A
N/A
0.43
N/A
0.68
N/A
N/A
N/A
Short Ratio
N/A
0.74
1.89
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
36.39
3.1
63.59
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Market Capitalization
17.57 B
2.02 M
82.48 B
N/A
4.35 B
96.58 K
955.54 M
50.36 M
N/A
N/A
Price To Earning
7.29
N/A
13.57
N/A
12.21
-0.22
9.18
N/A
N/A
35.48
Price To Sales
0.4
0.59
1.18
N/A
0.2
N/A
0.0285
N/A
N/A
1.23
Net Income
1.82 B
(9.42 M)
5.24 B
N/A
456 M
(627.79 K)
2.04 B
N/A
N/A
N/A
Shares Owned By Insiders
26.9
8.79
28.42
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Revenue
37.52 B
5.2 M
64.97 B
N/A
16.03 B
N/A
39.38 B
N/A
N/A
N/A
Year To Date Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
13.69
6.09
6.69
Working Capital
2.69 B
(752.65 K)
2.27 B
N/A
N/A
(794 K)
11.95 B
N/A
N/A
N/A
Profit Margin
0.0402
N/A
0.0852
N/A
-0.0209
N/A
0.0519
N/A
N/A
N/A
Current Valuation
43.74 B
7.22 M
124.48 B
N/A
4.75 B
912.76 K
1.11 B
N/A
N/A
N/A
Price To Book
0.71
0.54
293.44
N/A
0.67
N/A
0.99
N/A
N/A
1.58
Current Asset
11.13 B
N/A
9.23 B
N/A
N/A
N/A
25.84 B
N/A
N/A
N/A
Retained Earnings
N/A
(55.94 M)
(1.35 B)
N/A
(645.5 M)
(4.18 M)
13.37 B
N/A
N/A
N/A
Cash Position Weight
N/A
N/A
N/A
N/A
N/A
N/A
N/A
14.28
0.1
6.56
Equity Positions Weight
N/A
N/A
N/A
N/A
N/A
N/A
N/A
61.63
N/A
0.07
Shares Outstanding
563.24 M
1.89 M
253.3 M
N/A
1.78 B
965.83 K
185.7 M
N/A
N/A
N/A
Annual Yield
0.0309
N/A
0.0081
N/A
0.0789
N/A
0.0543
0.021
0.0041
0.0617
Return On Equity
0.0793
-3.32
0.12
N/A
-0.0574
N/A
0.0588
N/A
N/A
N/A
Z Score
N/A
N/A
N/A
N/A
0.6
N/A
N/A
N/A
N/A
N/A
Book Value Per Share
37.96
-1.08
-8.57
N/A
3.04
-1.18
99.76
N/A
N/A
N/A
Number Of Shares Shorted
N/A
30.34 K
2.6 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Minimum Initial Investment
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
2 K
Total Asset
71.96 B
1.14 M
56.21 B
N/A
51.52 B
3.19 K
54.41 B
215.11 M
243.16 M
347.66 M
Target Price
11.28
8.25
407.67
N/A
N/A
N/A
7.68
N/A
N/A
N/A
Last Dividend Paid
0.92
N/A
2.58
N/A
N/A
N/A
4.6
N/A
0.03
0.02
Price To Earnings To Growth
1.02
N/A
1.05
N/A
0.28
N/A
N/A
N/A
N/A
N/A
Earnings Per Share
3.1
-5.03
22.26
N/A
0.25
-0.63
0.35
N/A
N/A
N/A
Ten Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
4.84
6.0
Cash And Equivalents
2.13 B
1.61 M
908 M
N/A
3.52 B
1.15 K
5.11 B
N/A
N/A
N/A
Cash Per Share
3.78
0.06
3.97
N/A
1.97
N/A
25.52
N/A
N/A
N/A
Gross Profit
10.26 B
18.34 K
23.18 B
N/A
(853 M)
(143.88 K)
5.12 B
N/A
N/A
N/A
Day Typical Price
32.16
1.05
327.69
80.35
2.5
0.006
4.23
11.88
8.96
4.25
Accumulation Distribution
N/A
624.78
20822.6
N/A
0.0506
N/A
N/A
N/A
N/A
N/A
Market Facilitation Index
N/A
0.0
0.0
N/A
0.13
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
0.0
(0.50)
0.5115
(9,223,372,036,855)
0.3077
0.0
0.0
9.2 T
(9,223,372,036,855)
(9,223,372,036,855)
Period Momentum Indicator
N/A
(0.03)
3.33
(1.39)
0.04
N/A
N/A
0.15
(0.03)
(0.01)
Rate Of Daily Change
1.0
0.97
1.01
0.98
1.02
1.0
1.0
1.01
1.0
1.0
Day Median Price
32.16
1.05
327.06
80.35
2.51
0.006
4.23
11.88
8.96
4.25
Price Action Indicator
N/A
(0.03)
3.56
(0.70)
0.015
N/A
N/A
0.075
(0.01)
(0.01)
Coefficient Of Variation
(624.74)
(856.93)
(696.45)
(5,956)
846.1
N/A
25169.77
1873.74
2046.85
584.89
Mean Deviation
0.4289
3.56
1.16
1.31
2.13
N/A
1.27
0.4801
0.1662
0.1098
Jensen Alpha
(0.24)
(0.59)
(0.27)
0.0322
0.3795
N/A
(0.13)
(0.05)
(0)
0.014
Total Risk Alpha
(0.42)
(1.40)
(0.53)
(0.45)
(0.12)
N/A
(0.65)
(0.07)
(0.04)
(0.01)
Sortino Ratio
N/A
N/A
N/A
N/A
0.0895
N/A
N/A
(0.15)
(0.25)
(0.40)
Downside Variance
N/A
N/A
N/A
N/A
5.66
N/A
N/A
0.4204
0.2181
0.0625
Standard Deviation
1.29
5.13
1.74
2.57
2.89
N/A
4.2
0.6193
0.2865
0.1688
Kurtosis
42.66
3.59
8.54
5.86
1.47
N/A
11.15
0.0373
8.65
3.71
Potential Upside
N/A
7.32
2.06
5.93
5.61
N/A
N/A
1.03
0.3382
0.2375
Treynor Ratio
(0.97)
3.22
(2.43)
0.0739
(0.82)
N/A
0.0057
0.0382
0.0836
0.4625
Maximum Drawdown
10.14
23.76
11.25
16.62
12.99
N/A
34.02
2.8
1.91
0.9552
Variance
1.67
26.27
3.04
6.61
8.35
N/A
17.65
0.3836
0.0821
0.0285
Market Risk Adjusted Performance
(0.96)
3.23
(2.42)
0.0839
(0.81)
N/A
0.0157
0.0482
0.0936
0.4725
Risk Adjusted Performance
(0.12)
(0.08)
(0.10)
(0.01)
0.0977
N/A
0.0112
0.0384
0.0207
0.0954
Skewness
(6.37)
(1.06)
(2.15)
1.06
0.7885
N/A
0.4951
0.0305
(1.72)
1.16
Semi Deviation
N/A
N/A
N/A
N/A
2.03
N/A
N/A
0.5304
0.2597
0.0
Information Ratio
(0.26)
(0.14)
(0.22)
(0.07)
0.0737
N/A
(0.03)
(0.15)
(0.40)
(0.59)
Value At Risk
N/A
(7.91)
(2.82)
(4.56)
(4.09)
N/A
(2.98)
(1.02)
(0.33)
(0.24)
Expected Short fall
N/A
N/A
N/A
N/A
(2.95)
N/A
N/A
(0.58)
(0.23)
(0.29)
Downside Deviation
N/A
N/A
N/A
N/A
2.38
N/A
N/A
0.6484
0.467
0.25
Semi Variance
N/A
N/A
N/A
N/A
4.12
N/A
N/A
0.2813
0.0674
(0.02)

Fresenius Competition Performance Charts

Five steps to successful analysis of Fresenius Competition

Fresenius' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Fresenius SE in relation to its competition. Fresenius' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Fresenius in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Fresenius' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Fresenius SE, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Fresenius position

In addition to having Fresenius in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Business Services Thematic Idea Now

Business Services
Business Services Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Services theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Services Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Fresenius Pink Sheet

Fresenius financial ratios help investors to determine whether Fresenius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fresenius with respect to the benefits of owning Fresenius security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY